Like many bHLH TFs, ATOH1 itself is rarely mutated in brain tumors; its expression levels, however, are reported to be dysregulated in a number of brain tumor subtypes (Fu et al., 2019). This evidence concerns the gene ATOH1 and brain neoplasm.